Reconciliations of Non-GAAP Financial Measures September 30, 2026 (Unaudited) SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES 2026 OUTLOOK FFO, Normalized FFO, AFFO and Normalized AFFO The table below sets forth our 2026…
Reconciliations of Non-GAAP Financial Measures
September 30, 2026
(Unaudited)
SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
2026 OUTLOOK
FFO, Normalized FFO, AFFO and Normalized AFFO
The table below sets forth our 2026 guidance (per diluted common share):
Low
Net income attributable to Sabra Health Care REIT, Inc.
Add:
Depreciation and amortization of real estate assets
Depreciation and amortization of real estate assets related to unconsolidated joint ventures
Net gain on sales of real estate
FFO attributable to Sabra Health Care REIT, Inc.
Normalizing items
Normalized FFO attributable to Sabra Health Care REIT, Inc.
FFO attributable to Sabra Health Care REIT, Inc.
Stock-based compensation expense
Non-cash rental and related revenues
Non-cash interest expense
Other adjustments
AFFO attributable to Sabra Health Care REIT, Inc.
0.265
$
0.275
$
0.970
0.020
(0.110)
1.145 $
0.970
0.020
(0.110)
1.155
$
0.395
1.540
$
0.395
1.550
$
1.145 $
0.055
(0.015)
0.035
0.405
1.625 $
1.155
0.055
(0.015)
0.035
0.405
1.635
$
(0.025)
1.600 $
(0.025)
1.610
$
Normalizing items
Normalized AFFO attributable to Sabra Health Care REIT, Inc.
High
$
Earnings guidance above assumes:
•
low-single-digit Cash NOI growth for the triple-net portfolio at the midpoint, ignoring the impact of acquisitions, dispositions and
completed or planned tenant transitions;
•
average full-year Cash NOI growth for same store SHOP in the mid-teens;
•
general and administrative expenses at the midpoint of $63 million, which includes nearly $15 million of stock-based
compensation expense;
•
cash interest expense of $106 million at the midpoint;
•
weighted average share counts of 260 million and 261 million for Normalized FFO and Normalized AFFO, respectively; and
•
only investments, dispositions and capital markets activity completed as of November 2, 2026.
The foregoing guidance ranges reflect management's view of current and future market conditions. There can be no assurance that the
Company's actual results will not differ materially from the estimates set forth above. Except as otherwise required by law, the Company
assumes no, and hereby disclaims any, obligation to update any of the foregoing guidance ranges as a result of new information or new or
future developments.
See reporting definitions.
2
SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
FFO, Normalized FFO, AFFO and Normalized AFFO
(dollars in thousands, except per share data)
Net income attributable to Sabra Health Care REIT, Inc.
Add:
Depreciation and amortization of real estate assets
Depreciation and amortization of real estate assets related to
noncontrolling interests
Depreciation and amortization of real estate assets related to
unconsolidated joint ventures
Net loss (gain) on sales of real estate
Impairment of real estate
FFO attributable to Sabra Health Care REIT, Inc.
Write-offs of straight-line rental income receivable and lease
intangibles
Lease termination (income) expense, net
Loss on extinguishment of debt
Provision for (recovery of) loan losses and other reserves
Other normalizing items (1)
Normalized FFO attributable to Sabra Health Care REIT, Inc.
FFO attributable to Sabra Health Care REIT, Inc.
Stock-based compensation expense
Non-cash rental and related revenues
Non-cash interest expense
Non-cash portion of loss on extinguishment of debt
Provision for (recovery of) loan losses and other reserves
Other adjustments related to unconsolidated joint ventures
Other adjustments (2)
AFFO attributable to Sabra Health Care REIT, Inc.
Lease termination (income) expense, net
Cash portion of loss on extinguishment of debt
Other normalizing items (1)
Normalized AFFO attributable to Sabra Health Care REIT, Inc.
Amounts per diluted common share attributable to Sabra Health Care
REIT, Inc.:
Net income
FFO
Normalized FFO
AFFO
Normalized AFFO
Weighted average number of common shares outstanding, diluted:
Net income, FFO and Normalized FFO
AFFO and Normalized AFFO
Three Months Ended September 30,
2026
2025
Nine Months Ended September 30,
2026
2025
$
$
$
28,607
$
22,538
44,285
$
128,384
64,779
48,511
174,289
135,591
(124)
(40)
(368)
(40)
1,474
8,065
—
102,801
1,722
4,430
2,571
79,732
$
$
4,478
(29,652)
440
193,472 $
5,945
(5,544)
6,674
271,010
6,200
9,237
4,796
7,759
$
—
—
2,368
(9,012)
102,357
102,801
3,922
4,248
2,372
—
2,368
76
821
116,608
—
—
(9,359)
107,249
$
(1,518)
1,154
(240)
270
88,635
79,732
2,875
7,151
2,153
(1,730)
(240)
218
547
90,706
(1,518)
2,884
81
92,153
$
2,873
—
103,327
(8,410)
296,058
193,472
11,109
(1,005)
7,110
—
103,327
229
1,966
316,208
2,873
—
(8,430)
310,651
$
(1,518)
1,154
(640)
(14,166)
263,599
271,010
8,290
820
5,608
(1,730)
(640)
237
(15,535)
268,060
(1,518)
2,884
2,619
272,045
$
$
$
$
$
0.11
0.40
0.39
0.45
0.41
$
$
$
$
$
0.09
0.33
0.36
0.37
0.38
$
$
$
$
$
0.17
0.75
1.15
1.22
1.20
$
$
$
$
$
0.53
1.12
1.09
1.10
1.12
$
$
$
259,823,331
260,791,823
$
$
$
243,558,449
244,468,871
$
$
$
257,186,896
258,314,175
$
$
$
241,593,992
242,666,745
(1)
Other normalizing items for FFO and AFFO for the three and nine months ended September 30, 2026 include a $10.2 million deferred rent payment related to a triple-net lease.
Other normalizing items for FFO for the nine months ended September 30, 2025 include a $17.2 million gain reclassified from other comprehensive loss related to six previously
terminated interest rate swaps as the related forecasted transactions were determined to be probable not to occur and $3.4 million of transition expenses related to the
transition of SHOP communities to new operators. Other normalizing items for AFFO for the nine months ended September 30, 2025 include $3.4 million of transition expenses
related to the transition of SHOP communities to new operators. In addition, other normalizing items for FFO and AFFO include triple-net operating expenses, net of recoveries.
(2)
Other adjustments for the nine months ended September 30, 2025 include a $17.2 million gain reclassified from other comprehensive loss related to six previously terminated
interest rate swaps as the related forecasted transactions were determined to be probable not to occur.
See reporting definitions.
3
SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
EBITDA, Adjusted EBITDA, Adjusted EBITDA, as adjusted and Adjusted EBITDA, as adjusted, annualized
Net Debt and Net Debt to Adjusted EBITDA
(in thousands)
Three Months Ended
September 30, 2026
Net income
$
Interest
28,557
29,161
Income tax expense
71
Depreciation and amortization
64,779
EBITDA
122,568
Income from unconsolidated joint ventures
(2,230)
Distributions from unconsolidated joint ventures
1,607
Stock-based compensation expense
3,922
Acquisition and transaction costs
813
Write-offs of non-cash revenue and provision for loan losses
8,560
Other expense
184
Net loss on sales of real estate
8,065
Adjusted EBITDA
143,489
Adjustments for current period activity (1)
(10,312)
Adjusted EBITDA, as adjusted
$
133,177
Adjusted EBITDA, as adjusted, annualized
$
532,708
Secured debt
$
September 30, 2026
Revolving credit facility
42,416
126,503
Term loans
1,035,615
Senior unsecured notes
1,250,000
Consolidated Debt
2,454,534
Cash and cash equivalents
(36,240)
Net Debt
$
2,418,294
September 30, 2026
Net Debt
$
2,418,294
Adjusted EBITDA, as adjusted, annualized
$
532,708
Net Debt to Adjusted EBITDA
(1)
4.54x
Adjustments for current period activity give effect to the acquisitions and dispositions completed during the period as though such acquisitions and dispositions were completed
as of the beginning of the period and adjust for certain income and expense items that the Company does not believe are indicative of its operating results for the current
period.
See reporting definitions.
4
SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
Consolidated Statements of Income
Supplemental Information
(in thousands)
Three Months Ended September 30,
2026
Cash rental income
$
Nine Months Ended September 30,
2025
93,540
$
2026
88,946
$
277,383
2025
$
271,414
Deferred cash rent payment
10,166
—
10,166
—
Straight-line rental income
894
1,027
2,609
3,683
Write-offs of straight-line rental income receivable and lease
intangibles
(6,200)
(9,237)
(4,796)
(7,759)
Above/below market lease amortization
1,058
1,058
3,192
3,256
Operating expense recoveries
3,720
3,560
10,982
10,620
Rental and related revenues
$
103,178
See reporting definitions.
$
85,354
$
299,536
$
281,214
5
SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
Senior Housing Operating Portfolio (SHOP) Revenues and Cash NOI
(in thousands)
Three Months Ended
September 30, 2025
December 31, 2025
$
$
March 31, 2026
June 30, 2026
September 30, 2026
Revenues:
Resident fees and services
Resident fees and services
attributable to noncontrolling
interests
Resident fees and services - pro rata
92,017
(117)
$
91,900
108,434
$
(312)
$
108,122
116,685
$
(317)
$
116,368
128,802
$
(336)
$
128,466
143,164
(351)
$
142,813
Income from unconsolidated joint
ventures:
Resident fees and services
11,524
11,611
11,978
12,206
12,310
Resident fees and services not
included in same store (1)
(26,491)
(40,558)
(47,475)
(58,076)
(71,007)
Same store resident fees and services
76,933
$
79,175
$
80,871
$
82,596
$
84,116
Net income
22,517
$
27,147
$
40,813
$
(25,248) $
28,557
$
Adjustments:
Net income not related to SHOP
(14,590)
(17,533)
(30,050)
30,760
(17,879)
Depreciation and amortization
19,989
23,730
25,965
29,391
35,306
—
—
—
38
114
(619)
(73)
—
(29)
—
Net loss (gain) on sale of real estate
—
—
—
7,498
(6)
Income from unconsolidated joint
ventures
(1,226)
(1,652)
(1,912)
(2,224)
(2,230)
Net Operating Income attributable
to noncontrolling interests
(39)
(92)
(99)
(120)
(120)
Sabra's share of unconsolidated joint
ventures' Net Operating Income
4,034
4,061
4,262
4,511
4,604
Interest
Other income
Net Operating Income - pro rata
$
30,066
Cash Net Operating Income - pro rata $
30,071
Cash Net Operating Income not
included in same store (1)
(4,454)
Non-cash revenue and expense
adjustments
Same store Cash Net Operating
Income - pro rata
(1)
$
35,588
$
35,592
5
$
25,617
$
38,979
$
38,983
4
26,582
44,577
$
44,581
4
(9,010)
$
$
27,255
48,346
$
48,350
4
(11,728)
$
$
4
(15,751)
$
28,830
(18,981)
$
29,369
Includes adjustments for changes in the foreign currency exchange rate where applicable by applying the average exchange rate for the current period to prior period results.
See reporting definitions.
6
SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
Cash NOI
(in thousands)
Three Months Ended
September 30, 2026
Net income
$
28,557
Adjustments:
Depreciation and amortization
64,779
Interest
29,161
General and administrative
15,584
Provision for loan losses
2,368
Other expense
250
Net loss on sales of real estate
8,065
Income from unconsolidated joint ventures
(2,230)
Income tax expense
71
Net Operating Income attributable to noncontrolling interests
(120)
Sabra’s share of unconsolidated joint ventures’ Net Operating Income
Net Operating Income - pro rata
4,604
$
151,089
$
155,345
Non-cash revenue and expense adjustments
4,256
Cash Net Operating Income - pro rata
See reporting definitions.
7
SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
Cash NOI, Annualized Cash NOI and Annualized Cash NOI, as adjusted by Property Type
(in thousands)
Nine Months Ended September 30, 2026
Net income (loss)
Senior Housing
Skilled
Nursing/
Transitional
Care
Senior
Housing Leased
$
$
197,885
16,445
SHOP Consolidated
$
20,587
Total
Senior
Housing
SHOP Unconsolidated
$
6,366
$
Specialty
Hospitals
and Other
43,398
$
26,415
$
Other
Corporate
Total
18,997
$ (242,573) $
44,122
Adjustments:
Depreciation and amortization
60,712
8,209
90,662
—
98,871
14,485
—
221
174,289
Interest
564
438
152
—
590
—
—
86,195
87,349
General and administrative
—
—
—
—
—
—
—
47,265
47,265
Provision for loan losses
—
—
—
—
—
—
—
104,600
104,600
Impairment of real estate
440
—
—
—
—
—
—
—
440
Other (income) expense
—
—
(29)
—
(29)
—
—
3,017
2,988
Net (gain) loss on sales of real estate
(45,209)
—
7,492
—
7,492
8,065
—
—
(29,652)
Income from unconsolidated joint ventures
—
—
—
(6,366)
(6,366)
—
—
—
(6,366)
Income tax expense
—
—
—
—
—
—
—
1,275
1,275
Net Operating Income attributable to noncontrolling interests
—
—
(339)
—
(339)
—
—
—
(339)
Sabra’s share of unconsolidated joint ventures’ Net Operating Income
Net Operating Income - pro rata
—
$
214,392
$
212,057
Non-cash revenue and expense adjustments
—
$
25,092
$
26,059
(2,335)
Cash Net Operating Income - pro rata
Annualizing adjustments (1)
$
Reallocation adjustments (2)
278,651
$
278,651
$
118,525
$
33,123
40,879
13,376
13,376
$ 156,993
13
980
$
13,389
$ 157,973
5,042
72,252
18,431
$ 230,225
—
7,756
18,431
$ 237,981
60,146
$
7,756
$
13,376
$
—
7,064
—
Annualized Cash Net Operating Income, as adjusted - pro rata
118,525
967
66,594
Annualized Cash Net Operating Income - pro rata
—
$
178,671
$
—
$
178,671
$
(1)
—
$
48,965
$
49,339
—
$
18,997
$
18,998
374
1
9,831
$
59,170
62,524
$
(6,168)
$
3,354
$
$
12,830
$
(11,110)
$
1,720
$
—
13,376
—
$ 439,347
—
(980)
—
$ 438,367
—
142,509
—
$ 580,876
—
—
—
$ 580,876
Represents the annual effect of acquisitions, dispositions, lease modifications and scheduled rent increases completed during the period and mathematical adjustments needed to make Cash Net Operating Income for the period
representative of Cash Net Operating Income for a full year.
(2)
Adjustments to reflect Annualized Cash Net Operating Income from mortgage and construction loans receivable and preferred equity investments in the related property type of the underlying real estate.
See reporting definitions.
8
SABRA HEALTH CARE REIT, INC.
REPORTING DEFINITIONS
Adjusted EBITDA. Adjusted EBITDA is calculated as earnings before interest, taxes, depreciation and amortization (“EBITDA”) excluding the impact of merger-related costs, stock-based compensation expense under
the Company’s long-term equity award program and loan loss reserves. Adjusted EBITDA is an important non-GAAP supplemental measure of operating performance.
Annualized Cash Net Operating Income (“Annualized Cash NOI”). The Company believes that net income as defined by GAAP is the most appropriate earnings measure. The Company considers Annualized Cash
NOI an important supplemental measure because it allows investors, analysts and its management to evaluate the operating performance of its investments. The Company defines Annualized Cash NOI as
Annualized Revenues less operating expenses and non-cash revenues and expenses. Annualized Cash NOI excludes all other financial statement amounts included in net income and is presented at Sabra’s pro rata
share.
Annualized Revenues. The annual contractual rental revenues under leases and interest and other income generated by the Company’s loans receivable and other investments based on amounts invested and
applicable terms as of the end of the period presented. Annualized Revenues do not include tenant recoveries and are adjusted to reflect actual payments received related to the twelve months ended at the end of
the respective period for leases no longer accounted for on an accrual basis.
Cash Net Operating Income (“Cash NOI”). The Company believes that net income as defined by GAAP is the most appropriate earnings measure. The Company considers Cash NOI an important supplemental
measure because it allows investors, analysts and its management to evaluate the operating performance of its investments. The Company defines Cash NOI as total revenues less operating expenses and non-cash
revenues and expenses. Cash NOI excludes all other financial statement amounts included in net income and is presented at Sabra’s pro rata share.
Consolidated Debt. The principal balances of the Company’s revolving credit facility, term loans, senior unsecured notes and secured indebtedness as reported in the Company’s consolidated financial statements.
Funds From Operations (“FFO”) and Adjusted Funds from Operations (“AFFO”). The Company believes that net income as defined by GAAP is the most appropriate earnings measure. The Company also believes
that funds from operations, or FFO, as defined in accordance with the definition used by the National Association of Real Estate Investment Trusts (“Nareit”), and adjusted funds from operations, or AFFO (and
related per share amounts) are important non-GAAP supplemental measures of the Company’s operating performance. Because the historical cost accounting convention used for real estate assets requires
straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. However, since real estate values have historically risen or
fallen with market and other conditions, presentations of operating results for a real estate investment trust that uses historical cost accounting for depreciation could be less informative. Thus, Nareit created FFO
as a supplemental measure of operating performance for real estate investment trusts that excludes historical cost depreciation and amortization, among other items, from net income, as defined by GAAP. FFO is
defined as net income, computed in accordance with GAAP, excluding gains or losses from real estate dispositions and the Company’s share of gains or losses from real estate dispositions related to its
unconsolidated joint ventures, plus real estate depreciation and amortization, net of amounts related to noncontrolling interests, plus the Company’s share of depreciation and amortization related to its
unconsolidated joint ventures, and real estate impairment charges of both consolidated and unconsolidated entities when the impairment is directly attributable to decreases in the value of depreciable real estate
held by the entity. AFFO is defined as FFO excluding stock-based compensation expense, non-cash rental and related revenues, non-cash interest income, non-cash interest expense, non-cash portion of loss on
extinguishment of debt, provision for (recovery of) loan losses and other reserves, non-cash lease termination income and deferred income taxes, as well as other non-cash revenue and expense items (including
noncapitalizable acquisition costs, transaction costs related to operator transitions and organizational or other restructuring activities, gain/loss on derivative instruments, and non-cash revenue and expense
amounts related to noncontrolling interests) and the Company’s share of non-cash adjustments related to its unconsolidated joint ventures. The Company believes that the use of FFO and AFFO (and the related per
share amounts), combined with the required GAAP presentations, improves the understanding of the Company’s operating results among investors and makes comparisons of operating results among real estate
investment trusts more meaningful. The Company considers FFO and AFFO to be useful measures for reviewing comparative operating and financial performance because, by excluding the applicable items listed
above, FFO and AFFO can help investors compare the operating performance of the Company between periods or as compared to other companies. While FFO and AFFO are relevant and widely used measures of
operating performance of real estate investment trusts, they do not represent cash flows from operations or net income as defined by GAAP and should not be considered an alternative to those measures in
evaluating the Company’s liquidity or operating performance. FFO and AFFO also do not consider the costs associated with capital expenditures related to the Company’s real estate assets nor do they purport to be
indicative of cash available to fund the Company’s future cash requirements. Further, the Company’s computation of FFO and AFFO may not be comparable to FFO and AFFO reported by other real estate
investment trusts that do not define FFO in accordance with the current Nareit definition or that interpret the current Nareit definition or define AFFO differently than the Company does.
Net Debt. The principal balances of the Company’s revolving credit facility, term loans, senior unsecured notes and secured indebtedness as reported in the Company’s consolidated financial statements, net of
cash and cash equivalents as reported in the Company’s consolidated financial statements.
Net Debt to Adjusted EBITDA. The Company believes that net income as defined by GAAP is the most appropriate earnings measure. The Company considers Net Debt to Adjusted EBITDA an important
supplemental measure because it provides investors, analysts and its management with a meaningful indicator of the Company’s financial leverage and its capacity to service and repay debt from operating cash
flows. Net Debt to Adjusted EBITDA is calculated as Net Debt divided by Annualized Adjusted EBITDA, which is Adjusted EBITDA, as adjusted for annualizing adjustments that give effect to the acquisitions and
dispositions completed during the respective period as though such acquisitions and dispositions were completed as of the beginning of the period presented.
Net Operating Income (“NOI”). The Company believes that net income as defined by GAAP is the most appropriate earnings measure. The Company considers NOI an important supplemental measure because it
allows investors, analysts and its management to evaluate the operating performance of its investments. The Company defines NOI as total revenues less operating expenses. NOI excludes all other financial
statement amounts included in net income.
See reporting definitions.
9
SABRA HEALTH CARE REIT, INC.
REPORTING DEFINITIONS
Normalized FFO and Normalized AFFO. Normalized FFO and Normalized AFFO represent FFO and AFFO, respectively, adjusted for certain income and expense items that the Company does not believe are
indicative of its ongoing operating results. The Company considers Normalized FFO and Normalized AFFO to be useful measures to evaluate the Company’s operating results excluding these income and expense
items to help investors compare the operating performance of the Company between periods or as compared to other companies. Normalized FFO and Normalized AFFO do not represent cash flows from
operations or net income as defined by GAAP and should not be considered an alternative to those measures in evaluating the Company’s liquidity or operating performance. Normalized FFO and Normalized AFFO
also do not consider the costs associated with capital expenditures related to the Company’s real estate assets nor do they purport to be indicative of cash available to fund the Company’s future cash
requirements. Further, the Company’s computation of Normalized FFO and Normalized AFFO may not be comparable to Normalized FFO and Normalized AFFO reported by other real estate investment trusts that
do not define FFO in accordance with the current Nareit definition or that interpret the current Nareit definition or define FFO and AFFO or Normalized FFO and Normalized AFFO differently than the Company
does.
Senior Housing. Senior Housing communities include independent living, assisted living, continuing care retirement and memory care communities.
Senior Housing Operating Portfolio (“SHOP”). Senior Housing communities operated by third-party property managers pursuant to property management agreements.
Skilled Nursing/Transitional Care. Skilled Nursing/Transitional Care facilities include skilled nursing, transitional care and multi-license designation facilities.
Specialty Hospitals and Other. Includes psychiatric, acute care, long-term acute care and rehabilitation hospitals, facilities that provide residential services, which may include assistance with activities of daily
living, and other facilities not classified as Skilled Nursing/Transitional Care or Senior Housing.
See reporting definitions.
10